Skip to main content

Table 1 Characteristics of primary NIV patients

From: Outcomes of patients aged ≥80 years with respiratory failure initially treated with non-invasive ventilation in European intensive care units before and during COVID-19 pandemic

Feature

VIP2

COVIP

p-value

Entire group

Number of patients

491

206

 

Age

83.00 (81.0 to 86.0)

83.0 (81.0 to 85.0)

0.044

Female sex

251 (51.1)

67 (32.5)

< 0.001

SOFA

4.0 (3.0 to 6.0)

5.0 (3.0 to 7.0)

0.117

CFS

4.0 (3.0 to 6.0)

4.0 (3.0 to 6.0)

0.022

Frailty category

 Fit (CFS ≤ 3)

152 (31.1)

84 (42.9)

 

 Vulnerable (CFS = 4)

116 (23.7)

29 (14.8)

0.004

 Frail (CFS ≥ 5)

221 (45.2)

83 (42.3)

 

 LLST introduction during NIV

181 (37.3)

83 (40.5)

0.486

 30-day mortality

179 (36.5)

135 (65.5)

p < 0.001

 Intubation rate

86 (17.5)

76 (36.9)

p < 0.001

 NIV failure

222 (45.3)

157 (76.2)

p < 0.001

 ICU length of stay

4.0 (1.9 to 7.6)

8.0 (4.0 to 14.8)

p < 0.001

 Survivors

4.1 (2.0 to 7.8)

8.5 (5.6 to 21.2)

p < 0.001

 Non-survivors

4.0 (1.5 to 7.3)

7.6 (3.1 to 13.3)

p < 0.001

Without LLST on NIV*

Number of patients

304

122

 

Age

83.0 (81.0 to 86.0)

83.0 (81.0 to 84.8)

0.087

Female sex

154 (50.7)

41 (33.6)

0.002

SOFA

4.0 (3.0 to 6.0)

5.0 (3.0 to 7.0)

0.022

CFS

4.0 (3.0 to 5.0)

3.0 (3.0 to 5.0)

0.007

Frailty category

 Fit (CFS ≤ 3)

117 (38.6)

63 (54.8)

0.012

 Vulnerable (CFS = 4)

74 (24.4)

21 (18.3)

 Frail (CFS ≥ 5)

112 (37.0)

31 (27.0)

 30-day mortality

71 (23.4)

64 (52.5)

< 0.001

 Intubation rate

86 (28.3)

76 (62.3)

< 0.001

 NIV failure

115 (37.8)

86 (70.5)

< 0.001

  1. Categorical data is presented as n (%), while continuous variables are presented as median (interquartile range)
  2. * Data on LLST was incomplete in 7 patients